 | • レポートコード：MRC2012A0561 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗炎症薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗炎症薬の種類別市場規模（アスピリン、イブプロフェン、ナプロキセン、セレコキシブ、その他）、用途別市場規模（皮膚発疹、慢性関節炎、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Novartis、Merck & Co.、Abbott Laboratories、Sanofi、Johnson & Johnson、Amgen、Amgen、Pfizer、Eli Lilly、Bayer、Novacap、Kopran Ltd.、 ・地域別グローバル市場分析 2015年-2020年 ・抗炎症薬の北米市場（アメリカ、カナダ、メキシコ） ・抗炎症薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗炎症薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗炎症薬の南米市場（ブラジル、アルゼンチン） ・抗炎症薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アスピリン、イブプロフェン、ナプロキセン、セレコキシブ、その他 ・用途別分析：皮膚発疹、慢性関節炎、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Anti-inflammatory Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Anti-inflammatory Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Anti-inflammatory Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anti-inflammatory Drugs market has been segmented into
Aspirin
Ibuprofen
Naproxen
Celecoxib
Others
By Application, Anti-inflammatory Drugs has been segmented into:
Skin Rashes
Chronic Arthritis
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anti-inflammatory Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Anti-inflammatory Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anti-inflammatory Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Anti-inflammatory Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Anti-inflammatory Drugs Market Share Analysis
Anti-inflammatory Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anti-inflammatory Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anti-inflammatory Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Anti-inflammatory Drugs are:
Roche
Novartis
Merck & Co.
Abbott Laboratories
Sanofi
Johnson & Johnson
Amgen
Amgen
Pfizer
Eli Lilly
Bayer
Novacap
Kopran Ltd.
Among other players domestic and global, Anti-inflammatory Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-inflammatory Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-inflammatory Drugs, with price, sales, revenue and global market share of Anti-inflammatory Drugs in 2018 and 2019.
Chapter 3, the Anti-inflammatory Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-inflammatory Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Anti-inflammatory Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Anti-inflammatory Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Anti-inflammatory Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-inflammatory Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Aspirin
1.2.3 Ibuprofen
1.2.4 Naproxen
1.2.5 Celecoxib
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-inflammatory Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Skin Rashes
1.3.3 Chronic Arthritis
1.3.4 Other
1.4 Overview of Global Anti-inflammatory Drugs Market
1.4.1 Global Anti-inflammatory Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck & Co.
2.3.1 Merck & Co. Details
2.3.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck & Co. SWOT Analysis
2.3.4 Merck & Co. Product and Services
2.3.5 Merck & Co. Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott Laboratories SWOT Analysis
2.4.4 Abbott Laboratories Product and Services
2.4.5 Abbott Laboratories Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Amgen SWOT Analysis
2.7.4 Amgen Product and Services
2.7.5 Amgen Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Amgen SWOT Analysis
2.8.4 Amgen Product and Services
2.8.5 Amgen Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer SWOT Analysis
2.9.4 Pfizer Product and Services
2.9.5 Pfizer Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Eli Lilly SWOT Analysis
2.10.4 Eli Lilly Product and Services
2.10.5 Eli Lilly Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bayer
2.11.1 Bayer Details
2.11.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bayer SWOT Analysis
2.11.4 Bayer Product and Services
2.11.5 Bayer Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Novacap
2.12.1 Novacap Details
2.12.2 Novacap Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Novacap SWOT Analysis
2.12.4 Novacap Product and Services
2.12.5 Novacap Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Kopran Ltd.
2.13.1 Kopran Ltd. Details
2.13.2 Kopran Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Kopran Ltd. SWOT Analysis
2.13.4 Kopran Ltd. Product and Services
2.13.5 Kopran Ltd. Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Anti-inflammatory Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Anti-inflammatory Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-inflammatory Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Anti-inflammatory Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Anti-inflammatory Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-inflammatory Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Anti-inflammatory Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
4.5 South America Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Anti-inflammatory Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Anti-inflammatory Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Anti-inflammatory Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Anti-inflammatory Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Anti-inflammatory Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Anti-inflammatory Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
6.3 UK Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
6.4 France Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Anti-inflammatory Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Anti-inflammatory Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Anti-inflammatory Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
7.5 India Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Anti-inflammatory Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Anti-inflammatory Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Anti-inflammatory Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Anti-inflammatory Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Anti-inflammatory Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Anti-inflammatory Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Anti-inflammatory Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Anti-inflammatory Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Anti-inflammatory Drugs Price by Type (2015-2020)
11 Global Anti-inflammatory Drugs Market Segment by Application
11.1 Global Anti-inflammatory Drugs Sales Market Share by Application (2015-2020)
11.2 Global Anti-inflammatory Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Anti-inflammatory Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Anti-inflammatory Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Anti-inflammatory Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Anti-inflammatory Drugs Market Forecast (2021-2025)
12.2.2 Europe Anti-inflammatory Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Anti-inflammatory Drugs Market Forecast (2021-2025)
12.2.4 South America Anti-inflammatory Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Anti-inflammatory Drugs Market Forecast (2021-2025)
12.3 Anti-inflammatory Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Anti-inflammatory Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Anti-inflammatory Drugs Market Share Forecast by Type (2021-2025)
12.4 Anti-inflammatory Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Anti-inflammatory Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Anti-inflammatory Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Anti-inflammatory Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti-inflammatory Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti-inflammatory Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Anti-inflammatory Drugs Major Business
Table 9. Roche Anti-inflammatory Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Roche SWOT Analysis
Table 11. Roche Anti-inflammatory Drugs Product and Services
Table 12. Roche Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Anti-inflammatory Drugs Major Business
Table 15. Novartis Anti-inflammatory Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Novartis SWOT Analysis
Table 17. Novartis Anti-inflammatory Drugs Product and Services
Table 18. Novartis Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 20. Merck & Co. Anti-inflammatory Drugs Major Business
Table 21. Merck & Co. Anti-inflammatory Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Merck & Co. SWOT Analysis
Table 23. Merck & Co. Anti-inflammatory Drugs Product and Services
Table 24. Merck & Co. Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 26. Abbott Laboratories Anti-inflammatory Drugs Major Business
Table 27. Abbott Laboratories Anti-inflammatory Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Abbott Laboratories SWOT Analysis
Table 29. Abbott Laboratories Anti-inflammatory Drugs Product and Services
Table 30. Abbott Laboratories Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Anti-inflammatory Drugs Major Business
Table 33. Sanofi Anti-inflammatory Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Sanofi SWOT Analysis
Table 35. Sanofi Anti-inflammatory Drugs Product and Services
Table 36. Sanofi Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 38. Johnson & Johnson Anti-inflammatory Drugs Major Business
Table 39. Johnson & Johnson Anti-inflammatory Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Johnson & Johnson SWOT Analysis
Table 41. Johnson & Johnson Anti-inflammatory Drugs Product and Services
Table 42. Johnson & Johnson Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Amgen Basic Information, Manufacturing Base and Competitors
Table 44. Amgen Anti-inflammatory Drugs Major Business
Table 45. Amgen Anti-inflammatory Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Amgen SWOT Analysis
Table 47. Amgen Anti-inflammatory Drugs Product and Services
Table 48. Amgen Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Amgen Basic Information, Manufacturing Base and Competitors
Table 50. Amgen Anti-inflammatory Drugs Major Business
Table 51. Amgen Anti-inflammatory Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Amgen SWOT Analysis
Table 53. Amgen Anti-inflammatory Drugs Product and Services
Table 54. Amgen Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Pfizer Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Anti-inflammatory Drugs Major Business
Table 57. Pfizer Anti-inflammatory Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Pfizer SWOT Analysis
Table 59. Pfizer Anti-inflammatory Drugs Product and Services
Table 60. Pfizer Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 62. Eli Lilly Anti-inflammatory Drugs Major Business
Table 63. Eli Lilly Anti-inflammatory Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Eli Lilly SWOT Analysis
Table 65. Eli Lilly Anti-inflammatory Drugs Product and Services
Table 66. Eli Lilly Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Anti-inflammatory Drugs Major Business
Table 69. Bayer Anti-inflammatory Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Bayer SWOT Analysis
Table 71. Bayer Anti-inflammatory Drugs Product and Services
Table 72. Bayer Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Novacap Basic Information, Manufacturing Base and Competitors
Table 74. Novacap Anti-inflammatory Drugs Major Business
Table 75. Novacap Anti-inflammatory Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Novacap SWOT Analysis
Table 77. Novacap Anti-inflammatory Drugs Product and Services
Table 78. Novacap Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Kopran Ltd. Basic Information, Manufacturing Base and Competitors
Table 80. Kopran Ltd. Anti-inflammatory Drugs Major Business
Table 81. Kopran Ltd. Anti-inflammatory Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Kopran Ltd. SWOT Analysis
Table 83. Kopran Ltd. Anti-inflammatory Drugs Product and Services
Table 84. Kopran Ltd. Anti-inflammatory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global Anti-inflammatory Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 86. Global Anti-inflammatory Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global Anti-inflammatory Drugs Sales by Regions (2015-2020) (K Units)
Table 88. Global Anti-inflammatory Drugs Sales Market Share by Regions (2015-2020)
Table 89. Global Anti-inflammatory Drugs Revenue by Regions (2015-2020) (USD Million)
Table 90. North America Anti-inflammatory Drugs Sales by Countries (2015-2020) (K Units)
Table 91. North America Anti-inflammatory Drugs Sales Market Share by Countries (2015-2020)
Table 92. North America Anti-inflammatory Drugs Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Anti-inflammatory Drugs Revenue Market Share by Countries (2015-2020)
Table 94. Europe Anti-inflammatory Drugs Sales by Countries (2015-2020) (K Units)
Table 95. Europe Anti-inflammatory Drugs Sales Market Share by Countries (2015-2020)
Table 96. Europe Anti-inflammatory Drugs Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific Anti-inflammatory Drugs Sales by Regions (2015-2020) (K Units)
Table 98. Asia-Pacific Anti-inflammatory Drugs Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific Anti-inflammatory Drugs Revenue by Regions (2015-2020) (USD Million)
Table 100. South America Anti-inflammatory Drugs Sales by Countries (2015-2020) (K Units)
Table 101. South America Anti-inflammatory Drugs Sales Market Share by Countries (2015-2020)
Table 102. South America Anti-inflammatory Drugs Revenue by Countries (2015-2020) (USD Million)
Table 103. South America Anti-inflammatory Drugs Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa Anti-inflammatory Drugs Sales by Countries (2015-2020) (K Units)
Table 105. Middle East & Africa Anti-inflammatory Drugs Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa Anti-inflammatory Drugs Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa Anti-inflammatory Drugs Revenue Market Share by Countries (2015-2020)
Table 108. Global Anti-inflammatory Drugs Sales by Type (2015-2020) (K Units)
Table 109. Global Anti-inflammatory Drugs Sales Share by Type (2015-2020)
Table 110. Global Anti-inflammatory Drugs Revenue by Type (2015-2020) (USD Million)
Table 111. Global Anti-inflammatory Drugs Revenue Share by Type (2015-2020)
Table 112. Global Anti-inflammatory Drugs Sales by Application (2015-2020) (K Units)
Table 113. Global Anti-inflammatory Drugs Sales Share by Application (2015-2020)
Table 114. Global Anti-inflammatory Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 115. Global Anti-inflammatory Drugs Market Share Forecast by Regions (2021-2025)
Table 116. Global Anti-inflammatory Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 117. Global Anti-inflammatory Drugs Market Share Forecast by Type (2021-2025)
Table 118. Global Anti-inflammatory Drugs Sales Forecast by Application (2021-2025)
Table 119. Global Anti-inflammatory Drugs Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Anti-inflammatory Drugs Picture
Figure 2. Global Sales Market Share of Anti-inflammatory Drugs by Type in 2019
Figure 3. Aspirin Picture
Figure 4. Ibuprofen Picture
Figure 5. Naproxen Picture
Figure 6. Celecoxib Picture
Figure 7. Others Picture
Figure 8. Anti-inflammatory Drugs Sales Market Share by Application in 2018
Figure 9. Skin Rashes Picture
Figure 10. Chronic Arthritis Picture
Figure 11. Other Picture
Figure 12. Global Anti-inflammatory Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Anti-inflammatory Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Anti-inflammatory Drugs Sales Market Share by Manufacturer in 2019
Figure 33. Global Anti-inflammatory Drugs Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Anti-inflammatory Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Anti-inflammatory Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Anti-inflammatory Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Anti-inflammatory Drugs Revenue Market Share by Regions (2015-2020)
Figure 40. Global Anti-inflammatory Drugs Revenue Market Share by Regions in 2018
Figure 41. North America Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
Figure 42. Europe Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
Figure 44. South America Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Anti-inflammatory Drugs Sales and Growth Rate (2015-2020)
Figure 46. North America Anti-inflammatory Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Anti-inflammatory Drugs Sales Market Share by Countries (2015-2020)
Figure 48. North America Anti-inflammatory Drugs Sales Market Share by Countries in 2018
Figure 49. North America Anti-inflammatory Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Anti-inflammatory Drugs Revenue Market Share by Countries in 2018
Figure 51. United States Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Anti-inflammatory Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Anti-inflammatory Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Anti-inflammatory Drugs Revenue Market Share by Countries in 2019
Figure 57. Germany Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Anti-inflammatory Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Anti-inflammatory Drugs Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Anti-inflammatory Drugs Revenue Market Share by Regions 2019
Figure 65. China Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Anti-inflammatory Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Anti-inflammatory Drugs Sales Market Share by Countries in 2019
Figure 72. South America Anti-inflammatory Drugs Revenue Market Share by Countries in 2019
Figure 73. Brazil Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Anti-inflammatory Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Anti-inflammatory Drugs Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Anti-inflammatory Drugs Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Anti-inflammatory Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Anti-inflammatory Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Anti-inflammatory Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Anti-inflammatory Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Anti-inflammatory Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Anti-inflammatory Drugs Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Anti-inflammatory Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Anti-inflammatory Drugs Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
抗炎症薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-inflammatory Drugs Market The global Anti-inflammatory Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti-inflammatory Drugs Scope and Market Size Anti-inflammatory Dru…- 非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 抗炎症ペプチドの世界市場（～2026年） Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal's skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and…
- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…
- 抗腫瘍薬の世界市場（～2026年） Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It ha…